Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: AIDS Behav. 2018 May;22(5):1411–1422. doi: 10.1007/s10461-017-1822-6

Table 1.

Baseline characteristics by cohort and HIV status

Baseline characteristics Column No. (%)
Mean (SD)
P Value
WIHS
(N = 1744)
MACS
(N = 980)
HIV−
(n = 552)
HIV+
(n = 1192)
P Value HIV−
(n = 386)
HIV+
(n = 594)
Race .005 <.001
    White 93 (17) 277 (23) 257 (67) 307 (52)
    African American/black 370 (67) 713 (60) 105 (27) 226 (38)
    Other 89 (16) 202 (17) 24 (6) 61 (10)
Annual income, $ .001 <.001
    <$10,000 232 (42) 612 (51) 65 (17) 157 (26)
    $10,000–$30,000 206 (37) 385 (32) 85 (22) 211 (36)
    ≥$30,000 114 (21) 195 (16) 236 (61) 226 (38)
Receipt of mental health services <.001 <.001
    No 495 (90) 939 (79) 341 (88) 465 (78)
    Yes 57 (10) 253 (21) 45 (12) 129 (22)
Alcohol consumptiona <.001 .04
    <1 drink/week 219 (40) 630 (53) 43 (11) 92 (16)
    1–7 [14] drinks/week 275 (50) 483 (40) 312 (81) 471 (79)
    >7 [14] drinks/week 58 (11) 79 (7) 31 (8) 31 (5)
Illicit drug useb <.001 .01
    No 321 (69) 955 (80) 316 (84) 441 (77)
    Yes 141 (30) 237 (20) 62 (16) 131 (23)
Framingham risk score, mean (SD) 8.1 (6.8) 8.7 (5.9) .08 13.4 (1.6) 13.5 (1.6) .23
Ever diagnosed as having diabetes .54 .02
    No 416 (75) 882 (74) 227 (72) 384 (65)
    Yes 136 (25) 310 (26) 109 (38) 210 (35)
Body mass index, mean (SD) 30.5 (4.8) 29.4 (10.5) .002 26.6 (4.1) 25.5 (3.7) <.001
HIV RNA suppressionc NA NA
    Suppressed (<200 copies/mL) 539 (45) 417 (70)
    Unsuppressed (≥200 copies/mL) 653 (55) 177 (30)
CD4+ T-cell countc NA NA
    ≥500 cells/mm3 452 (38) 260 (44)
    300–500 cells/mm3 342 (29) 156 (26)
    <300 cells/mm3 398 (33) 178 (30)
Cumulative ART exposure, mean years (SD)c NA 5.8 (2.6) NA 7.2 (2.8)
Depressive risk pattern <.001 <.001
    Low 319 (58) 335 (45) 202 (52) 201 (34)
    Moderate 174 (31) 366 (31) 58 (15) 201 (34)
    High N/A 304 (25) 89 (23) 130 (22)
    Decreased N/A 79 (7) N/A N/A
    Severe 59 (11) 108 (9) 37 (10) 62 (10)

WIHS women’s interagency HIV study, MACS multicenter AIDS cohort study, ART antiretroviral therapy

a

1–7 drinks/week for women, 1–14 drinks/week for men; >7 drinks/week for women, >14 drinks/week for men

b

Includes crack cocaine, other forms of cocaine, methamphetamines (speed, meth, or ice), and ecstasy

c

Among HIV-seropositive participants only